Internal Medicine, Gastroenterology · Delray Beach, FL
NPI
1598751679
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4675 Linton Blvd, Suite 202
Delray Beach, FL, 33445
Phone (561) 495-5700
Groups this clinician bills Medicare through
Medicare paid, 2024
$418K
14,876 services
Medicare patients, 2024
931
Average age 77
Drug cost, 2024
$521K
2,096 prescriptions
Company payments, 2025
$32K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Morris S Naus was code J3380 (injection, vedolizumab, intravenous, 1 mg), 9,900 times for 21 patients. In total Morris S Naus billed 14,876 services in 53 codes, and Medicare paid $418K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 9,900 | 21 | $17.24 | $171K |
| 99213 Office E&M - Established | Office | 490 | 332 | $67.91 | $33K |
| 99214 Office E&M - Established | Office | 283 | 215 | $98.26 | $28K |
| 43239 Upper GI Endoscopy | Facility | 235 | 229 | $77.76 | $18K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 105 | 105 | $184.08 | $19K |
| 99223 Hospital E&M - Initial | Facility | 91 | 89 | $138.37 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 82 | 57 | $93.52 | $7,669 |
| 45385 Colonoscopy - Lesion Removal | Facility | 82 | 82 | $216.78 | $18K |
| 45378 Lower GI Endoscopy - Other | Facility | 64 | 64 | $146.15 | $9,354 |
| 96372 Injection Administration | Office | 57 | 12 | $11.40 | $650 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 55 | 12 | $0.96 | $53.07 |
| 99232 Hospital E&M - Subsequent | Facility | 48 | 42 | $63.13 | $3,030 |
| 99203 Office E&M - New | Office | 44 | 44 | $63.38 | $2,789 |
| 43450 Digestive/Gastrointestinal | Facility | 43 | 42 | $32.63 | $1,403 |
| 99204 Office E&M - New | Office | 41 | 41 | $122.70 | $5,031 |
By year: 2022 $2.1M for 124,896 services; 2023 $912K for 42,458 services; 2024 $418K for 14,876 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 27 | 24 | $8.65 | $234 |
Medicare prescription drug claims, 2024
In 2024, the drug Morris S Naus prescribed most often to Medicare patients was Pantoprazole Sodium, with 495 prescriptions and refills. In total Morris S Naus wrote 2,096 Medicare prescriptions that cost $521K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 495 | 1,403 | 182 | $9,220 |
| Omeprazole Generic | 270 | 773 | 89 | $4,534 |
| Esomeprazole Magnesium Generic | 160 | 390 | 67 | $5,807 |
| Voquezna Vonoprazan Fumarate | 104 | 126 | 30 | $77K |
| Metronidazole Generic | 72 | 72 | 49 | $549 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 61 | 61 | 61 | $10K |
| Famotidine Generic | 53 | 149 | 24 | $542 |
| Dicyclomine Hcl Generic | 53 | 80 | 28 | $1,129 |
| Linzess Linaclotide | 50 | 82 | 17 | $43K |
| Dexlansoprazole Dr Dexlansoprazole | 48 | 95 | 14 | $14K |
| Sucralfate Generic | 39 | 52 | 19 | $963 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 38 | 38 | 38 | $6,163 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 33 | 33 | 26 | $204 |
| Colestipol Hcl Generic | 33 | 59 | 14 | $2,887 |
| Xifaxan Rifaximin | 33 | 35 | Under 11 | $109K |
Brand drugs: 413 claims; generic drugs: 1,683 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Morris S Naus $32K ($32K in general payments such as food, travel and fees) from 21 companies. The largest payer was Phathom Pharmaceuticals, Inc. with $24K.
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. PHAT | 32 | $24K |
| Celltrion USA Inc. 068270.KS | 11 | $5,430 |
| Abbvie Inc. ABBV | 38 | $1,032 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $312 |
| Lilly USA, LLC LLY | 19 | $256 |
| Pfizer Inc. PFE | 18 | $253 |
| Ardelyx, Inc. ARDX | 6 | $243 |
| Janssen Biotech, Inc. JNJ | 8 | $131 |
| Genzyme Corporation SNY | 3 | $93 |
| QOL Medical, LLC | 2 | $86.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.